CN Stock MarketDetailed Quotes

688373 Shanghai Micurx Pharmaceutical

Watchlist
  • 5.11
  • +0.02+0.39%
Market Closed Apr 30 15:00 CST
3.35BMarket Cap-7166P/E (TTM)

Shanghai Micurx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Micurx Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 26, 2024

Revenue(YoY)

33.02M

+91.10%
EPS(YoY)

-0.16

-77.78%
Analyst Rating

Strong Buy

May 1, 2024

Shanghai Micurx Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 260.000M--
--2024/FY-- / 166.000M--
Mar 28, 20242023/FY90.776M / 103.000M--
Mar 25, 20232022/FY48.207M / 50.000M--
--2021/FY7.660M / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 260.000M--
--2024/FY-- / 166.000M--
Mar 28, 20242023/FY90.776M / 103.000M--
Mar 25, 20232022/FY48.207M / 50.000M--
--2021/FY7.660M / ----

Shanghai Micurx Pharmaceutical Earnings Reports

  • Shanghai Mengke Pharmaceutical Co., Ltd. Report for the first quarter of 2024

    Apr 26 00:00

  • Summary of the 2023 Annual Report of Shanghai Mengke Pharmaceutical Co., Ltd.

    Mar 28 00:00

  • Shanghai Mengke Pharmaceutical Co., Ltd. 2023 Annual Report

    Mar 28 00:00

  • Shanghai Mengke Pharmaceutical Co., Ltd. 2023 Annual Results Express Announcement

    Feb 23 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 1, 2024

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      25.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg